جست‌وجوی استاد و پژوهشگر

• Radiation Oncology
• Medical Physics
• Treatment Planning Techniques
• +۵ مورد دیگر

Dr. Sotirios Stathakis is Chief of Physics at the Mary Bird Perkins Cancer Center (2023–Present) and Associate Director of the Medical Physics Division at the University of Texas Health Science Center San Antonio (2017–2022). He holds an Adjunct Professor position at Louisiana State University's Department of Physics and Astronomy (2023–Present). His expertise lies in radiation oncology and medical physics, with a focus on patient-specific quality assurance, dose verification, and advanced treatment techniques like adaptive radiation therapy and SBRT. Education: Ph.D., Medical Physics, University of Patras (2005) M.S., Medical Physics, University of Aberdeen (1997) B.S., Physics (minor in Mathematics and Computer Science), University of Waterloo (1995) Research Interests: Patient-specific quality assurance Daily dose verification Treatment planning techniques Adaptive radiation therapy Stereotactic body radiation therapy (SBRT) Automation and workflow optimization in radiation oncology Publications: Over 20 peer-reviewed articles since 2020, focusing on topics like Monte Carlo simulations, AI-driven beam analysis, and AAPM task group recommendations for IMRT verification. Key themes include improving dose accuracy, equipment validation, and clinical implementation of advanced radiation technologies. Grants & Awards: Not explicitly listed in provided text. Labs/Teams: Collaborates with institutions like Fox Chase Cancer Center, South Texas Veterans Health Administration, and LSU on medical physics research and clinical applications.

• Medical Physics
• Radiation Oncology
• Therapeutic Radiology
• +۷ مورد دیگر

Huixiao Chen is an Assistant Professor and Clinical Medical Physicist II in the Department of Therapeutic Radiology at Yale School of Medicine. She holds a primary appointment in Therapeutic Radiology and is actively engaged in clinical and research activities related to radiation oncology physics. Assistant Professor, Department of Therapeutic Radiology, Yale School of Medicine Clinical Medical Physicist II, Therapeutic Radiology Education: Resident, Yale University (2016) Postdoctoral Fellow, Harvard University (2013) Postdoctoral Fellow, Virginia Commonwealth University (2011) PhD, University of Heidelberg, Germany (2010) MS, Zhejiang University, China (1998) BS, Zhejiang University, China (1995) Huixiao Chen's research centers on medical physics in radiation oncology, with a focus on treatment planning optimization, dosimetry, and image-guided radiotherapy. Her work includes the development and evaluation of advanced radiotherapy techniques such as VMAT and SBRT, with applications in spine, lung, and prostate cancers. She has contributed to improving the accuracy of dose calculations using Monte Carlo methods and has explored the impact of patient motion on treatment delivery. Her research also extends to the design of clinical devices to support safe and effective radiotherapy for diverse patient populations. Her recent publications demonstrate a consistent focus on enhancing the precision and efficiency of radiotherapy. Key themes include multicriteria optimization in treatment planning, dosimetric validation of radiochromic films, and the development of supportive devices for image-guided radiotherapy. These works reflect a strong commitment to advancing clinical medical physics through both computational and engineering innovations. Scientific Contributions: Characterization of GafchromicTM EBT4 film for clinical dosimetry Design of a small-footprint couch-top support for heavy patients in IGRT Application of multicriteria optimization in VMAT planning for spine and prostate cancers Comparison of Monte Carlo vs. pencil beam algorithms in lung SBRT Analysis of diaphragm motion effects on spine SBRT Huixiao Chen has collaborated with researchers such as Emily Draeger and Zhe Jay Chen on various projects. While no formal students or grants are listed, her role as a clinical medical physicist and faculty member suggests active mentorship and potential involvement in funded research. She is a key contributor to the medical physics team at Yale, ensuring high standards in treatment planning and delivery.

Christian Rønn Hansenمشاهده پروفایل

دانشیار

• Radiation Therapy
• Head and Neck Cancer
• Treatment Planning
• +۷ مورد دیگر

Christian Rønn Hansen is an Associate Professor at the Department of Clinical Research, University of Southern Denmark , specializing in radiation therapy and oncology. His work spans head and neck cancer, prostate cancer, and glioma treatment planning, with a focus on advanced radiation techniques like VMAT, IMRT, and hypofractionation. Academic Affiliation : Department of Clinical Research, University of Southern Denmark Research Collaborations : KI (Karolinska Institute), OUH (Odense University Hospital), Danish Head and Neck Cancer Group (DAHANCA) Research Interests : Christian's research integrates artificial intelligence with magnetic resonance imaging for treatment adaptation, clinical trial quality assurance for radiation therapy, and pattern of failure analysis in head and neck cancer. His work also addresses thromboembolic risk in glioma patients and proton therapy applications for grade 1–3 gliomas. Scientific Contributions : His recent publications include systematic reviews on loco-regional failure patterns in head and neck cancer (2025), national data solutions for radiation oncology (2025), and AI-driven prostate volume analysis in hypo-fractionated radiotherapy (2025). He contributed to the 2023 ACTA ONCOLOGICA AWARD-winning work and leads discussions on international radiotherapy quality assurance standards. Scientific Awards : ACTA ONCOLOGICA AWARD (2023)

• Radiation Oncology
• Therapeutic Radiology
• Cancer Treatment
• +۸ مورد دیگر

Dr. Patrick Oh serves as an Assistant Professor of Therapeutic Radiology at Yale School of Medicine, practicing as a radiation oncologist at Yale Cancer Center and Smilow Cancer Hospital. He specializes in treating thoracic and genitourinary cancers, as well as hematologic, cutaneous, and metastatic malignancies with an emphasis on individualized, holistic patient care to optimize both disease outcomes and quality of life. His educational background includes: BS from Duke University MD from Stony Brook University School of Medicine Preliminary Medicine Intern at NYU Langone Hospital-Long Island Resident Physician in Radiation Oncology at Yale New Haven Hospital (served as Chief Resident) Gamma Knife Cranial Radiosurgery Certification from Cleveland Clinic Dr. Oh's research focuses on reducing radiation-induced toxicities, particularly cardiopulmonary effects, and expanding the role of radiation therapy across various cancer types. His clinical expertise encompasses advanced radiotherapy techniques including stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT/VMAT), and image-guided radiation therapy (IGRT). Professional recognition includes: RSNA Roentgen Resident Research Award (awarded June 7, 2025) Dr. Oh is dedicated to medical education, actively mentoring residents and medical students with emphasis on communication skills and patient-centered care. He maintains active professional memberships including the American Society for Therapeutic Radiology (2021-present), where he serves on the Board of the Korean American Society for Therapeutic Radiation Oncology (2024-present), and the American Society of Clinical Oncology (2018-present). He treats both adult and pediatric patients and accepts new appointments through Yale Medicine.

Laura Fitzgerald Hall Allenمشاهده پروفایل

استادیار

• Radiation Oncology
• Cancer Treatment Technologies
• Breast Cancer Research
• +۴ مورد دیگر

Laura Fitzgerald Hall Allen, MD serves as an Assistant Professor in the Department of Radiation Oncology at Wake Forest University School of Medicine, Winston-Salem campus. She is board certified in radiation oncology and provides clinical cancer treatment services at the Atrium Health Wake Forest Baptist Hayworth Cancer Center in High Point, NC. Wake Forest University School of Medicine - Faculty Member Atrium Health Wake Forest Baptist - Clinical Provider Hayworth Cancer Center - Primary Practice Location Dr. Allen received her undergraduate education from Tulane University and earned her medical degree from the Medical College of Georgia School of Medicine in 1995. She completed her Internal Medicine residency at Emory Healthcare in 1996, followed by specialized training in Radiation Oncology at Memorial Sloan Kettering Cancer Center in 2000. Additional training was completed at Wake Forest University Baptist Medical Center in 2018. Dr. Allen specializes in comprehensive radiation oncology with expertise across multiple cancer types including breast, prostate, lung, and gastrointestinal cancers. Her technical proficiency spans External Beam Radiation, Image-Guided Radiotherapy, Intensity Modulated Radiotherapy (IMRT), and Volumetric Arc Radiotherapy (VMAT). She is deeply committed to patient-centered care, treating each patient as if they were family members, with the mission of bringing Wake Forest University School of Medicine's expertise into community practice settings. Her clinical approach emphasizes personalized treatment plans for patients navigating challenging cancer journeys. American Board of Radiology certification in Radiation Oncology Member of the American Society for Therapeutic Radiation and Oncology Dr. Allen maintains an exceptional patient satisfaction record with a 4.9/5.0 rating based on 81 verified patient reviews. Patients consistently praise her compassionate communication style, thorough explanations of medical conditions, attentive listening skills, and dedication to addressing concerns. Her practice accepts numerous insurance providers across the Wake Forest Baptist Health system, serving patients at the High Point location with office hours Monday through Friday from 8:00 AM to 5:00 PM.

Sebastiaan Breedveldمشاهده پروفایل

دانشیار

• Radiation Therapy
• Applied Mathematics
• Decision-Making
• +۳ مورد دیگر

Dr. Sebastiaan Breedveld is an Associate Professor in the Department of Radiation Oncology at Erasmus University Medical Center in Rotterdam, The Netherlands. His research focuses on improving radiation therapy through applied mathematics, multi-criteria optimization, and automated treatment planning. He developed the clinically implemented Erasmus-iCycle algorithm and leads projects like TROTS (Radiotherapy Optimisation Test Set). Education includes a PhD in Medical Physics (cum laude) from Erasmus University Rotterdam and an MSc in Applied Mathematics from Delft University of Technology. Research interests center on developing computational methods for real-time, personalized radiotherapy. Key areas include: Large-scale optimization for treatment planning Deep learning for instantaneous dose prediction Multi-criteria decision analysis for balancing treatment trade-offs Proton therapy and VMAT techniques High-performance computing applications Recent publications demonstrate strong focus on AI-driven automation in brachytherapy, IMPT robustness, and FLASH proton therapy. Work consistently addresses clinical translation of mathematical optimization. Significant scientific awards include: NWO Vidi Grant (2021) for INSTORAD project NWO Veni Grant (2016) MCDM Doctoral Dissertation Award (2015) Erasmus MC Efficiency Grant (2015) PhD with honors (2013) Leads research group supervising 2 post-docs, 11 PhD students, and numerous master/bachelor projects. Major grants support work in proton therapy optimization and automated planning systems. Developed TROTS dataset for benchmarking radiotherapy optimization algorithms and collaborates internationally through projects like BiCycle for automated brachytherapy planning.

Stephanie E. Combsمشاهده پروفایل

استاد

• Radiation Oncology
• Radiation Therapy
• Highly Conformal Radiation Therapy
• +۸ مورد دیگر

Prof. Dr. Stephanie E. Combs is a leading academic in Radiation Oncology at Technische Universität München (TUM), holding the position of Professor and Chair of the Department of Radiation Oncology. She also serves as the Dean of the TUM Faculty of Medicine since 2022. Her expertise spans highly conformal radiation therapy techniques (e.g., IMRT/IGRT/ART, proton, and carbon ion therapy), with a focus on brain and skull base tumors, pediatric oncology, gastrointestinal oncology, and biomarker-driven therapies. Prof. Combs studied medicine in Heidelberg and the United States, completed postdoctoral training in Heidelberg, and became Vice Chair of Radiation Oncology there before joining TUM in 2014. She has held leadership roles, including heading the TUM Senate from 2019 to 2022. Her research emphasizes precision medicine, radiation biology, and translational radiotherapy innovations. Her awards include the Basic/Translational Senior Science Award (2019), Robert Janker Award (2012), and multiple honors from German and international radiation oncology societies. Her work bridges clinical practice and research, with contributions to guidelines on target delineation for glioblastoma and skull base tumors. Prof. Combs’ publications focus on advancing radiation techniques, radiomics, and personalized therapy, with over 300 peer-reviewed articles. She leads initiatives in education, including a Master of Science program in Radiation Biology, and collaborates internationally in translational research.

Reid Townsonمشاهده پروفایل

استاد مدعو

• Radiation Transport
• Medical Physics
• Monte Carlo Simulation
• +۳ مورد دیگر

Dr. Reid Townson is an Adjunct Professor at the Department of Physics, Carleton University , and a Research Officer in Metrology at the National Research Council Canada . His research focuses on the development and application of the EGSnrc Monte Carlo radiation transport software toolkit , enabling high-precision simulations of electron, positron, and photon transport for medical and metrological applications. Primary Role: Research Officer, Metrology at National Research Council Canada Academic Role: Adjunct Professor at Carleton University Key Affiliation: National Research Council Canada Research Interests span radiation transport modeling, radiation dosimetry, Monte Carlo simulation software development, and the application of computational physics to emerging medical technologies. His work involves simulating ionization chambers, radiotherapy devices, and complex radiation scenarios to advance dose calculation accuracy and detector calibration. Publications emphasize Monte Carlo simulation techniques for radiation therapy (e.g., VMAT, IMRT, RapidArc), gamma-ray spectrometry benchmarks, and EGSnrc toolkit enhancements. His contributions include detector modeling, dose verification algorithms, and GPU-accelerated computation frameworks. Student Opportunities are highlighted through research projects involving EGSnrc, though specific student names are not listed. He utilizes platforms like GitHub for collaborative development.

Huijun Xuمشاهده پروفایل

دانشیار

• Medical Physics
• Radiation Therapy
• Treatment Planning Optimization
• +۵ مورد دیگر

Huijun Xu, PhD, is an Associate Professor in the Department of Radiation Oncology at the University of Maryland School of Medicine, where she serves as the lead physicist for the University of Maryland Capital Region Medical Center. She holds certification from the American Board of Radiology in Therapeutic Radiologic Physics (2016). Education 2008 : B.S. in Applied Physics, Shanghai Jiao Tong University 2013 : Ph.D. in Medical Physics, Virginia Commonwealth University 2015 : Medical Physics Residency, University of Maryland Research Focus Dr. Xu's research centers on advancing precision in radiation therapy through computational methods. Key areas include: Probabilistic treatment planning for managing anatomical uncertainties (organ motion, delineation variations) Robust optimization frameworks for IMRT/VMAT Automation of quality assurance processes Dosimetry innovations for brachytherapy and electron therapy Publication Trends Her recent work (2014–2021) demonstrates a progression from foundational research on uncertainty management in prostate radiotherapy toward clinical implementation of automation tools. Key themes include robust optimization algorithms, system-specific treatment planning validation (e.g., RayStation, CyberKnife), and efficiency improvements for lung SBRT and electron therapy workflows. Certifications American Board of Radiology, Therapeutic Radiologic Physics (2016)

Joshua Schiffمشاهده پروفایل

استادیار

• Radiation Oncology
• Advanced Radiotherapy Techniques
• Cancer Treatment
• +۴ مورد دیگر

Dr. Joshua P. Schiff is an Assistant Professor of Clinical Radiation Oncology at the Keck School of Medicine, University of Southern California (USC), with primary clinical practice at the Norris Comprehensive Cancer Center. He specializes in advanced radiotherapy techniques for diverse cancer types, including intensity-modulated radiation therapy (IMRT), volumetric-modulated arc therapy (VMAT), and motion management strategies. His research focuses on improving treatment outcomes through adaptive radiotherapy and biology-guided approaches. Education & Training: Bachelor’s in Biopsychology (University of California, Santa Barbara) M.D. (Tulane University School of Medicine, inducted into Alpha Omega Alpha Honor Society) Radiation Oncology Residency (Washington University School of Medicine, Chief Resident) Internal Medicine Internship (Cedars-Sinai Medical Center) His research emphasizes innovative radiotherapy technologies such as MR-guided adaptive radiotherapy (SMART) and CT-guided stereotactic adaptive radiotherapy (CT-STAR). He leads clinical trials exploring motion management and biology-guided strategies to enhance precision while minimizing toxicity. Key contributions include pioneering studies on pancreatic, liver, and thoracic cancers treated with advanced techniques. Awards: Roentgen Resident/Fellow Research Award (Radiological Society of North America, 2024) Alpha Omega Alpha Honor Medical Society (2019) Dr. Schiff’s work spans publications in high-impact journals like International Journal of Radiation Oncology and Radiotherapy and Oncology . He actively collaborates on grants focused on adaptive radiotherapy implementation and has contributed to professional organizations such as ASTRO and the American Medical Association.

• Radiation Oncology
• Breast Cancer
• Gynecologic Oncology
• +۸ مورد دیگر

Lindsay M. Burt, MD, is a Clinical Associate Professor in the Department of Radiation Oncology at the University of Utah, affiliated with the Huntsman Cancer Institute. She specializes in advanced radiation therapy techniques including IMRT, SBRT, SRS, IGRT, VMAT, APBI, and HDR/LDR brachytherapy, with clinical focus areas in brain tumors, breast cancer, gynecologic oncology, and pediatric radiation therapy. B.A. in Biology-Chemistry, Claremont McKenna College M.D., University of Utah School of Medicine Residency, University of Utah Department of Radiation Oncology Dr. Burt's research spans clinical trials, translational studies, and database analyses in oncology. Her work addresses treatment optimization for breast cancer, endometrial cancer, glioblastoma, vulvar cancer, and meningioma, with emphasis on radiation protocols, dosimetry, and patient outcomes. She has contributed to studies on fertility preservation in pediatric cervical cancer and disparities in cancer care. Recent publications highlight her expertise in radiation fractionation practices, toxicity management, and protocol evaluations. While no explicit scientific awards are mentioned, her leadership roles include Chair of the Association of Residents in Radiation Oncology (ARRO) Executive Committee and active membership in ASTRO subcommittees. Dr. Burt's clinical practice at Huntsman Cancer Institute and Sugar House Health Center demonstrates commitment to patient-centered care, evidenced by consistently high patient satisfaction ratings and qualitative feedback praising her communication, empathy, and technical expertise.

John V. Hegdeمشاهده پروفایل

دانشیار

• Radiation Oncology
• Clinical Evaluation of Novel Cancer Treatments
• Advanced Radiotherapy Techniques
• +۵ مورد دیگر

Dr. John V. Hegde is an Associate Professor in the Department of Radiation Oncology at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). He specializes in advanced radiotherapy techniques, including stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), and intensity-modulated radiotherapy (IMRT), with a focus on breast cancer and central nervous system malignancies. His clinical expertise is complemented by research in state-of-the-art imaging to enhance cancer care. Education : Dual Bachelor of Science degrees from Indiana University, Medical Degree from Harvard Medical School, Residency at UCLA. Research Interests center on clinical evaluation of multidisciplinary cancer treatments incorporating radiotherapy and innovative imaging approaches. His work spans central nervous system tumors , breast cancer , and radiation physics , with over 25 peer-reviewed publications. Scientific Honors include four consecutive Super Doctors® Rising Stars designations (2020–2024) and multiple Los Angeles Magazine Top Doctors awards (2021–2024). His publications highlight expertise in pseudoprogression analysis in gliomas automated radiotherapy planning brachytherapy for lymphoma image-guided treatment protocols

Erik Korevaarمشاهده پروفایل

پژوهشگر

• Proton Therapy
• Radiation Oncology
• Head and Neck Cancer
• +۴ مورد دیگر

Erik Korevaar is a dedicated researcher at University Medical Center Groningen specializing in radiation oncology, with particular expertise in proton therapy applications for various cancer types. His research focuses on developing and optimizing advanced radiation techniques to improve treatment outcomes while reducing side effects for cancer patients. His primary research interests include: Proton Therapy (including Proton Arc Therapy) Intensity Modulated Radiation Therapy (IMRT) Volumetric Modulated Arc Therapy (VMAT) Treatment Planning and Optimization Algorithms Head and Neck Cancer Radiation Therapy Esophageal Cancer Radiation Therapy Radiation-Induced Toxicity Reduction Dr. Korevaar's recent work has demonstrated significant clinical benefits of proton therapy, particularly in reducing pneumonia incidence in esophageal cancer patients and improving treatment precision for head and neck cancers. His research on proton arc therapy shows potential advantages over conventional radiation techniques in terms of both efficacy and safety profiles. His scientific contributions have been published in high-impact journals including Physics in Medicine and Biology, Medical Physics, and the International Journal of Radiation Oncology Biology Physics. His work has been presented at numerous international conferences on radiation oncology and medical physics.

• Radiation Oncology
• Esophageal Cancer
• Chemoradiation Therapy
• +۳ مورد دیگر

Pim Damen serves as a Researcher within the Radiotherapy department at Erasmus MC, a leading academic medical center. His professional focus centers on advancing esophageal cancer treatment through rigorous clinical investigation of radiation therapy techniques, with emphasis on optimizing patient outcomes and minimizing treatment-related complications. Research Interests: Dr. Damen's work spans Radiation Oncology with specialization in esophageal cancer therapeutics. He actively investigates Chemoradiation Therapy protocols, Proton Therapy applications, and the critical impact of radiation-induced lymphopenia on survival rates. His research compares advanced modalities including Intensity-Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), and Intensity Modulated Proton Therapy (IMPT) to evaluate toxicity profiles, surgical mortality risks, and long-term patient recovery metrics. Publication Trends: Recent works (2024-2025) demonstrate consistent focus on comparative effectiveness of radiation techniques for esophageal cancer. Key themes include proton versus photon therapy outcomes, lymphopenia as a survival biomarker, and toxicity analysis of IMRT versus VMAT delivery systems. These studies collectively advance precision oncology by establishing evidence-based parameters for radiation dosing, treatment sequencing, and complication management. Scientific Awards: No awards, fellowships, or honors were documented in the available source materials. Advising and Grants: The provided information contains no details regarding graduate student supervision, mentorship activities, or externally funded research grants. Laboratory Affiliations: While Damen's clinical research involves multi-institutional collaboration (notably with MD Anderson Cancer Center), no dedicated laboratory facilities or specialized research teams were specified in the source text.

Byong Yong Yiمشاهده پروفایل

استاد

• Radiation Oncology Physics
• Tumor Tracking
• Medical Physics
• +۳ مورد دیگر

Dr. Byong Yong Yi is a Professor in the Department of Radiation Oncology at the University of Maryland School of Medicine. He holds administrative roles as Director of Proton Physics and Director of the Medical Physics Residency Program. Dr. Yi joined the university in 2005 after 16 years as Chief Medical Physicist and Professor at Asan Medical Center and University of Ulsan School of Medicine in Seoul, Korea. Education and Training: B.A. in Physics, Yonsei University, Seoul (1982) M.S. in Physics, Yonsei University, Seoul (1984) Ph.D. in Physics, Yonsei University, Seoul (1992) Junior Medical Physicist, Hanyang University, Seoul (1987-1989) Certifications: American Board of Radiology (Physics, 2008) Korean Board of Medical Physics (1993) Dr. Yi's research focuses on Radiation Oncology Physics and Tumor Tracking , with innovations including dose-rate-regulated therapy (DRRT) for real-time tumor tracking and tomographic image generation via background subtraction (TIBS). His work advances motion management in radiotherapy, proton therapy, and 4D treatment planning. His publications emphasize real-time adaptive radiotherapy , IMRT/VMAT optimization, EPID-based dosimetry, and novel devices like GammaPod™. Recent trends show dedicated work in motion compensation, 4D dose reconstruction, and clinical implementation of tracking systems. Notable Grants: NIH R01: "Radiotherapy with Dose-Rate Regulated Tracking" (2009-2016, $1.17M direct costs) NIH R01: "Personalized Motion Management for 4D Lung SBRT" (2013-2018, $447K) Maryland Industrial Partnership: "Extending Raven QA for Patient-Specific QA" (2014-2017, $200K) Dr. Yi founded the CAMPEP-accredited Medical Physics Residency Program at Maryland and leads the Proton Physics division, collaborating extensively on clinical and technical radiotherapy advancements.